
Journal Menu
► ▼ Journal Menu-
- Vaccines Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
10 July 2025
Vaccines | Section Restructuring
The journal Vaccines (ISSN: 2076-393X) is organized into topical Sections focusing on specific research areas within vaccine research, utilization, and immunization. Under the guidance of Editor-in-Chief Prof. Dr. Ralph A. Tripp and the Section Editors-in-Chief, the journal has decided to reorganize its topical sections to enhance navigation for authors and readers. The table below outlines both the original and the new section structures.
Original Sections | New Sections | |
1. | “Vaccines against Infectious Diseases” | “Vaccines against Tropical and Other Infectious Diseases” |
2. | “Vaccines against Tropical and Other Infectious Diseases” | “Vaccination Against Cancer and Chronic Diseases” |
3. | “Therapeutic Vaccines and Antibody Therapeutics” | “Influenza Virus Vaccines” |
4. | “Cancer Vaccines and Immunotherapy” | “HIV Vaccines” |
5. | “Influenza Virus Vaccines” | “Human Papillomavirus Vaccines” |
6. | “HIV Vaccines” | “Hepatitis Virus Vaccines” |
7. | “Human Papillomavirus Vaccines” | “COVID-19 Vaccines and Vaccination” |
8. | “Hepatitis Virus Vaccines” | “Veterinary Vaccines” |
9. | “COVID-19 Vaccines and Vaccination” | “Epidemiology and Vaccination” |
10. | “Veterinary Vaccines” | “Vaccines and Public Health” |
11. | “Epidemiology” | “Vaccine Design, Development, and Delivery” |
12. | “Human Vaccines and Public Health” | “Vaccines, Clinical Advancement, and Associated Immunology” |
13. | “Vaccine Adjuvants” | “Pathogens-Host Immune Boundaries” |
14. | “Attenuated/Inactivated/Live and Vectored Vaccines” | “Vaccine Advancement, Efficacy and Safety” |
15. | “Innate and Adaptive Immunity in Vaccination” | “Nucleic Acid (DNA and mRNA) Vaccines” |
16. | “Clinical Immunology” | |
17. | “Cellular/Molecular Immunology” | |
18. | “Pathogens-host Immune Interface” | |
19. | “Vaccination Optimization” | |
20. | “Vaccine Efficacy and Safety” | |
21. | “DNA and mRNA Vaccines” |
For more detailed information, please visit the following link: https://www.mdpi.com/journal/vaccines/sections. The Special Issues and their respective publications in the original Sections will be transferred to the new Sections.
Vaccines Editorial Office